Hutch News

Oncology Insights with Dr. Petros Grivas - Episode 7

Oncology Insights with Dr. Petros Grivas - Episode 7

Dr. Tom Lynch on Leadership, Innovation and Cancer Research
Hutch NewsJanuary 29, 2026
Oncology Insights with Dr. Petros Grivas - Episode 6

Oncology Insights with Dr. Petros Grivas - Episode 6

Dr. Heather Parsons on innovations in breast cancer care
Hutch NewsJanuary 28, 2026
Oncology Insights with Dr. Petros Grivas - Episode 4

Oncology Insights with Dr. Petros Grivas - Episode 4

Dr. Vidhya Nair gets to Meet the Greek
Hutch NewsDecember 16, 2025
Patient stories, provider advice mark invasive lobular breast cancer awareness event

Patient stories, provider advice mark invasive lobular breast cancer awareness event

Fred Hutch experts discuss ILC’s hormonal risk factors, screening recommendations and new research
Hutch NewsOctober 27, 2025
The body remembers: traces of breastfeeding linger in blood for decades

The body remembers: traces of breastfeeding linger in blood for decades

From the Sasamoto research group, Public Health Sciences Division
Science SpotlightAugust 27, 2025
Every mile counts: Thousands unite for Fred Hutch Obliteride

Every mile counts: Thousands unite for Fred Hutch Obliteride

More than 5,000 cyclists, walkers, runners and volunteers brought color, energy and connection to Fred Hutch Cancer Center’s annual bike ride and walk/run
Hutch NewsAugust 19, 2025
Panorama actual de las tasas de supervivencia del cáncer de mama triple negativo metastásico

Panorama actual de las tasas de supervivencia del cáncer de mama triple negativo metastásico

Del Laboratorio Hurvitz, División de Investigaciones Clínicas
Science SpotlightJuly 23, 2025
Saying goodbye to a community partner and friend

Saying goodbye to a community partner and friend

Bridgette Hempstead, founder of Cierra Sisters and staunch health equity research advocate, remembered as a force for underserved patients
Hutch NewsJanuary 10, 2025
Turning grief into purpose

Turning grief into purpose

Lynn Lippert started fundraising for research at Fred Hutch as a patient and now her partner, Sal Jepson, continues to donate to honor all that she stood for
Hutch NewsDecember 10, 2024
10 years in, HICOR’s efforts boost cancer care’s value

10 years in, HICOR’s efforts boost cancer care’s value

Fred Hutch’s Value in Cancer Care Initiative celebrates a decade of data and crucial collaborations between providers, payers and patients
Hutch NewsNovember 22, 2024
New funding drives six breast cancer studies

New funding drives six breast cancer studies

Scientists from Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium receive $1.7M in grants from Breast Cancer Research Foundation
Hutch NewsNovember 04, 2024
Fred Hutch Breast Sexual Health Clinic supports patients’ intimacy needs

Fred Hutch Breast Sexual Health Clinic supports patients’ intimacy needs

No matter what stage of treatment, providers create safe space
Hutch NewsOctober 30, 2024
From overlooked to understood, a Black woman’s case gets the attention it deserves

From overlooked to understood, a Black woman’s case gets the attention it deserves

Partnership is key to making patients of color feel respected
Hutch NewsOctober 24, 2024
Mammogram vans remove barriers that people face accessing breast cancer screening

Mammogram vans remove barriers that people face accessing breast cancer screening

Fred Hutch focuses on improving screening in under-resourced communities
Hutch NewsOctober 23, 2024
A promising antibody-drug conjugate for treating brain metastases in breast cancer patients

A promising antibody-drug conjugate for treating brain metastases in breast cancer patients

From the Hurvitz Lab, Clinical Research Division
Science SpotlightOctober 16, 2024
Young breast cancer patient’s self-exam and self-advocacy leads to cancer diagnosis

Young breast cancer patient’s self-exam and self-advocacy leads to cancer diagnosis

Gillian McDonald chooses Fred Hutch for care, including participating in clinical trials that led to being selected for proton therapy
Blog PostsSeptember 27, 2024
Sacituzumab govitecán para el cáncer de mama metastásico triple negativo

Sacituzumab govitecán para el cáncer de mama metastásico triple negativo

De la Dra. Sara Hurvitz, División de Investigación Clínica
Science SpotlightJune 19, 2024
Cost-effective device trains immune cells to kill tumor cells

Cost-effective device trains immune cells to kill tumor cells

From the Matthias Stephan Lab, Translational Science & Therapeutics Division
Science SpotlightJune 19, 2024